Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer

6 Jan 2014

Abstract excerpt

// Nader Al Nakouzi 1,2,6 , Sophie Cotteret 1,2,6 , Frédéric Commo 2,6 , Catherine Gaudin 1,2,6 , Shanna Rajpar 1,2,5,6 , Philippe Dessen 3,6 , Philippe Vielh 2,4,6 , Karim Fizazi 1,2,5,6 and Anne Chauchereau 1,2,6 1 Prostate Cancer Group, INSERM U981, Gustave Roussy, Villejuif, F-94805, France; 2 INSERM U981, LabEx LERMIT, Gustave Roussy, 3 INSERM U985, Gustave Roussy; 4 Department of Pathology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genomics and Chromatin Dynamics
Share to Prostate Cancer Treatment and Research
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24525428
DOI: 10.18632/oncotarget.1574

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancerPMID 24525428Read ↗

Molecular mechanisms of docetaxel resistance in prostate cancerSemantic proximity Read ↗

Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAsSemantic proximity Read ↗

Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cellsSemantic proximity Read ↗

Single-Cell Transcriptomics Analysis Identifies Nuclear Protein 1 as a Regulator of Docetaxel Resistance in Prostate Cancer CellsSemantic proximity Read ↗

Exploration and Identification of Potential Therapeutic Targets and Biomarkers for Docetaxel Resistant Prostate CancerSemantic proximity Read ↗

PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.Semantic proximity Read ↗

LncRNA PCBP1-AS1-mediated AR/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance.Semantic proximity Read ↗

Exploration of the influence of GOLGA8B on prostate cancer progression and resistance of castration-resistant prostate cancer to cabazitaxelSemantic proximity Read ↗

Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate CancerSemantic proximity Read ↗

Identification of Key Genes and Molecular Mechanisms Associated With Docetaxel Resistance in Castration Resistant Prostate Cancer Based on Bioinformatics AnalysisSemantic proximity Read ↗

Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxelSemantic proximity Read ↗

Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.